Market Overview

UPDATE: KeyBanc Capital Markets Initiates Innospec at Buy on Positioning, Acquisition Outlook

Related IOSP
Benzinga's Volume Movers
Stocks Hitting 52-Week Highs
Sigma-Aldrich, PHE Partner for Certified Reference Materials (Zacks)

KeyBanc Capital Markets initiated coverage on Innospec (NASDAQ: IOSP) with a Buy rating and a $40 price target.

KeyBanc Capital Markets said, "We are initiating coverage of Innospec Inc. (IOSP-NASDAQ) with a BUY rating and $40 price target. Its leading market position in its core Fuel Additives business offers a stable earnings stream and returns, while a solid position as a producer of surfactants for the personal care market adds to its attractive returns. On top of this, we believe that IOSP possesses an opportunity to grow its oilfield chemicals business while also expanding its personal care business both organically and through bolt-on acquisitions.

Innospec closed at $29.80 on Thursday.

Latest Ratings for IOSP

May 2015Singular ResearchInitiates Coverage onBuy
Feb 2014Monness Crespi HardtMaintainsBuy
Feb 2014CJS SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for IOSP
View the Latest Analyst Ratings

Posted-In: KeyBanc Capital MarketsAnalyst Color Initiation Intraday Update Analyst Ratings


Related Articles (IOSP)

Get Benzinga's Newsletters